Cite
LONG-TERM SAFETY OF BIOSIMILAR MEDICINAL PRODUCTS – KEY FOR ADMINISTRATION?
MLA
Octav Ginghină. “Long-Term Safety of Biosimilar Medicinal Products – Key for Administration?” FARMACIA, vol. 67, Feb. 2019, pp. 18–26. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........5aaf60ec44d93fa82e5b5ed0d997e222&authtype=sso&custid=ns315887.
APA
Octav Ginghină. (2019). Long-Term Safety of Biosimilar Medicinal Products – Key for Administration? FARMACIA, 67, 18–26.
Chicago
Octav Ginghină. 2019. “Long-Term Safety of Biosimilar Medicinal Products – Key for Administration?” FARMACIA 67 (February): 18–26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........5aaf60ec44d93fa82e5b5ed0d997e222&authtype=sso&custid=ns315887.